作者
Elizabeth M Molyneux, Rosemary Rochford, Beverly Griffin, Robert Newton, Graham Jackson, Geetha Menon, Christine J Harrison, Trijn Israels, Simon Bailey
发表日期
2012/3/31
来源
The Lancet
卷号
379
期号
9822
页码范围
1234-1244
出版商
Elsevier
简介
Burkitt's lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma and is the fastest growing human tumour. The disease is associated with Epstein-Barr virus and was one of the first tumours shown to have a chromosomal translocation that activates an oncogene (c-MYC). Burkitt's lymphoma is the most common childhood cancer in areas where malaria is holoendemic. The incidence is very high in immunosuppressed patients in non-endemic areas, especially when associated with HIV infection. Outcome with intensive chemotherapy has improved and is now excellent in children, but the prognosis is poor in elderly adults. The success of intensive treatment relies on good supportive care. The therapy offered in oncology units in low-income countries is not as aggressive as in centres in high-income countries and outcomes are less successful. Adjuvant monoclonal antibody therapy with rituximab shows …
引用总数
201220132014201520162017201820192020202120222023202411525360525756696670656030
学术搜索中的文章
EM Molyneux, R Rochford, B Griffin, R Newton… - The Lancet, 2012